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a b s t r a c t
Cryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus type 16
(HPV16) complexed with fragments of antibody (Fab) from three different neutralizing monoclonals
(mAbs): H16.1A, H16.14J, and H263.A2. The structure-function analysis revealed predominantly mono-
valent binding of each Fab with capsid interactions that involved multiple loops from symmetry related
copies of the major capsid protein. The residues identiﬁed in each Fab-virus interface map to a
conformational groove on the surface of the capsomer. In addition to the known involvement of the FG
and HI loops, the DE loop was also found to constitute the core of each epitope. Surprisingly, the epitope
mapping also identiﬁed minor contributions by EF and BC loops. Complementary immunological assays
included mAb and Fab neutralization. The speciﬁc binding characteristics of mAbs correlated with
different neutralizing behaviors in pre- and post-attachment neutralization assays.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Human papillomaviruses (HPVs) cause epithelial tumors and are
the etiologic agents of numerous anogenital and oropharyngeal
cancers (Bosch et al., 1995; Walboomers et al., 1999; Crow, 2012).
Identiﬁcation of neutralization-sensitive epitopes on the capsid
protein structures (conformational epitopes) support investigations
to develop improved recombinant vaccines that maximize effective
and long-term antibody-mediated protection against multiple HPV
types (Culp et al., 2007). As one of the major cancer-causing HPV
types, HPV16 is extensively studied (Bosch et al., 1995; Crow, 2012;
Castillo, 2013; Marur et al., 2010; Burk et al., 2009), and together
with HPV18 comprises a major target for vaccine development
(Zhao et al., 2012; Monie et al., 2009). Since the life cycle of HPVs
relies on differentiation of basal cells into keratinocytes, purifying
high titer virus stocks for structural studies is difﬁcult. Therefore,
other production methods have been developed as an alternative
for studies of the native virions. Virus-like particles (VLPs) are com-
prised of only the major structural protein, L1, and are not infectious
since they are devoid of viral genome (Kirnbauer et al., 1992).
Quasivirions (QV16) and pseudovirions (PsV16) were used for our
structural analysis and neutralization assays (Christensen, 2005;
Buck et al., 2005) as both types of HPV 16 particles contain a mock
genome.
Papillomaviruses form a T¼7 icosahedral, non-enveloped 55
to 60 nm diameter capsid containing a circular dsDNA genome of
8 kb. The capsid is comprised of 360 copies of the L1 structural
protein and up to 72 copies of the L2 minor structural protein
(Buck et al., 2005; Baker et al., 1991). Five L1 proteins intertwine to
form each capsomer, 72 of which make up one capsid. Twelve of
the 72 capsomers lie on an icosahedral ﬁve fold vertex and are
described as pentavalent capsomers. The remaining 60 capsomers
are each surrounded by six other capsomers and are consequently
referred to as hexavalent capsomers. The C-terminus, or “C-
terminal arm,” of each L1 protein extends along the capsid ﬂoor
to interact with the neighboring capsomer and then returns to
the original donor capsomer (Wolf et al., 2010; Cardone et al.,
2014; Lee et al., 2014). Inter-capsomer disulﬁde bonds are for-
med between cysteine C428 and C175, which stabilize the capsid
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structure and play an important role in virus maturation (Cardone
et al., 2014; Buck et al., 2005). The core of the capsomer is composed
of the common viral structural motif, the antiparallel β-strands
BIDG and CHEF (Rossmann and Johnson,1989), which are connected
by surface loops of BC, DE, EF, FG, and HI. Nearly all conformational
epitopes are located on one or more of these outwardly facing
surface-exposed loops (Carter et al., 2003). Our knowledge of these
epitopes has been largely obtained from mAb/Fab binding and
neutralization assays (Culp et al., 2007; Christensen et al., 1996;
Day et al., 2007; Day et al., 2008), hybrid virus loop exchange studies
(Christensen et al., 2001), and previous structural analysis (Lee et al.,
2014; Bishop et al., 2007). These complementary studies represent
an important approach to analyze the nature of conformational
epitopes, neutralization mechanisms, and how the host immune
system recognizes and responds to the virus.
H16.V5 is a well-characterized HPV16-speciﬁc neutralizing
mAb induced by HPV16 L1 VLPs. This mAb has been extensively
used in major HPV vaccination trials and is an especially important
tool in inhibition-based HPV serological assays (Zhao et al., 2012;
Carter et al., 2003; Christensen et al., 1996; Wang et al., 1997; Rizk
et al., 2008; Deschuyteneer et al., 2010). The neutralizing anti-
bodies of H16.1A, H16.14J, and H263.A2 were raised against HPV16
L1 VLP (Christensen et al., 1996) or hybrid capsids (Christensen
et al., 1991). Like H16.V5, based on previous immunological
studies, all three antibodies were thought to recognize portions
of the FG and HI loops. The H16.V5 neutralization mechanism has
been shown to be one of capsid stabilization that consequently
inhibits the conformational changes required during entry (Zhao
et al., 2012; Rizk et al., 2008; Deschuyteneer et al., 2010; Chen
et al., 2011). Although many immunological studies of H16.V5
neutralization have been published, no information on H16.V5 Fab
has been recorded. For the three antibodies H16.1A, H16.14J, and
H263.A2, details of neutralization are unknown.
Previously, two HPV16-H16.V5 complex cryo-EM maps of 20 Å
(Zhao et al., 2014) and 10 Å (Lee et al., 2014) resolution showed that
H16.V5 Fab binding induced conformational changes and bound
predominately to the hexavalent capsomers. Here we present three
new cryo-EM structures of HPV16 complexed with the Fabs from
the speciﬁc mAbs, H16.1A, H16.14J, and H263.A2 at 12 Å resolu-
tion (Fig. 1). Atomic structures of the component parts, virus and
Fab, were ﬁtted into the cryo-EM complex maps using rigorous
ﬁtting algorithms developed for this purpose (Rossmann et al.,
2005, 2001; Fabiola and Chapman, 2005). For each complex, the
resulting pseudo-atomic model was used to deﬁne the Fab binding
site and identify the amino acids that likely comprise the complex
conformational epitope (Rossmann et al., 2005; Fabiola and
Chapman, 2005; Hafenstein et al., 2009). We found that besides
the well-known FG and HI loops, the DE loop also composes the
core of each footprint; however, additional participation by BC and
EF loops vary between the antibodies. The structural results were
complemented with immunological studies that showed Fabs from
all four neutralizing antibodies are also neutralizing, albeit at higher
molar concentrations. H16.1A and H16.14J Fabs can distinguish
conformational changes of the capsid after host cell attachment,
whereas H16.V5 and H263.A2 do not. Differences in the antibody
footprints correlate with these immunological differences. Thus, the
structure-function study predicts the neutralization mechanisms to
be a combination of stabilization and cross-linking.
Experimental procedures
Preparation of HPV16 quasivirus and pseudovirus
QV16 virions are comprised of HPV16 L1 and L2 proteins and
encapsidate the cottontail rabbit papillomavirus genome (CRPV)
containing the SV40 origin of replication. QV16 were prepared as
described previously (Brendle et al., 2010; Mejia et al., 2006; Pyeon
et al., 2005). PsV16 virions are comprised of the HPV16 L1 and L2
proteins and contain the pYSEAP (alkaline-phosphatase producing
genome). Brieﬂy, HPV16 sheLL plasmid (kindly provided by John
Schiller, NIH) was transfected together with linear CRPV/SV40ori
DNA (QV) or pYSEAP (PsV) into 293TT cells and prepared as
described previously (Buck et al., 2005; Pastrana et al., 2004). PsVs
were puriﬁed by Optiprep gradient centrifugation as previously
described (Buck et al., 2004). QVs were allowed to mature overnight
and then pelleted by centrifugation. The centrifuged pellet was re-
suspended in 1 M NaCl 0.2 M Tris, pH 7.4. After CsCl gradient
puriﬁcation, the lower band was collected, concentrated, and
dialyzed against PBS, as described previously (Lee et al., 2014). The
concentrated QVs were applied to Formavar-coated copper grids,
stained with 2% phosphotungstic acid, and analyzed for integrity
and concentration on a JEOL JEM 1400 electron microscope.
Preparation of antibody and Fabs
Antibodies of H16.V5, H16.1A, H16.14J and H263.A2 were
generated in Balb-C mice as described previously (Christensen
et al., 1996; Christensen et al., 1991). Hybridomas were acclimated
to animal component free media (BD) and supernatant was
puriﬁed on Protein A or G columns (Pierce). Fab was prepared by
digestion with papain in the presence of cysteine (Pierce). Purity of
the Fab was assessed by the lack of the fragment crystallizable (Fc)
portion and integrity of the Fab was determined by ELISA. Anti-
body and Fab protein concentrations were determined by absor-
bance spectrometry at a wavelength of 280 nm.
Sequencing of antibody heavy and light chains
The hybridoma cells were pelleted by centrifugation and RNA
was extracted using TRIzols Reagent (Life Technologies). Total RNA
was treated with DNase I (RNase-free) (New England Biolabs) to
digest potentially contaminating DNA in the sample. cDNAs were
synthesized from treated RNA with the RevertAid First Strand cDNA
synthesis kit (Thermo Scientiﬁc). The cDNAs were used as a tem-
plate for PCR and ampliﬁed using Pfu Turbo DNA Polymerase
(Agilent) or Choice Taq DNA polymerase (Denville). PCR ampliﬁca-
tion used primers previously described by Wang et al. (2000).
Immunoglobulin heavy chains were ampliﬁed using the isotype
speciﬁc constant region 30 primer and two highly degenerate 50
primers. The light chains were ampliﬁed using the 30 degenerate
kappa chain constant region primer and the 50 kappa chain frame-
work one region universal degenerate primer. Prior to sequencing,
PCR products were puriﬁed using the QIAquick PCR Puriﬁcation Kit
(Qiagen). The same primers used for PCR ampliﬁcation were also
used as sequencing primers to obtain initial sequences. Resolution
of the 50 and 30 ends of the sequence required sequence speciﬁc
primers. The 263.A2 light chain required cloning into pUC19 to
completely resolve the sequence.
Neutralization assays
The neutralization activity of mAbs and Fabs was investigated
by pre- and post-virus attachment assays in 293TT cells. In the
pre-attachment assay, PsVs were pre-incubated with mAb or Fabs
at dilutions ranging from 66 nM to 0.067 pM for 1 h at 37 1C before
adding to cells. For the post-attachment assay, PsVs were incu-
bated with 293TT cells for 1 h at 4 1C to allow for attachment. Cells
were washed 1x with media prior to incubation with mAbs or
Fabs. 72 h later 30 μl of the cell culture supernatant was assayed
with 4-Nitrophenyl phosphate disodium salt hexahydrate (pNPP)
(Sigma) and the optical density was determined by absorbance
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Fig. 1. Cryo-EM reconstructions of HPV16 and HPV16-Fab complexes. Representative regions of cryo-EM micrographs are shown for (A1) the HPV16 capsid (EM Database,
EMD 5993) (16), (B1) HPV16 capsids complexed with H16.V5 (EM Database, EMD 5994) (16), (C1) H16.1A, (D1) H16.14J, and (E1) H16.263A2. (A2–E2) The 3-D complexes
were radially colored according to the distance from the center of the capsid (color bar indicated) and surface rendered at 1σ. A small black pentagon indicates the position of
a pentavalent capsomer. (A3–E3) In the zoomed in views of the complex maps the separate heavy chain and light chain Fab densities can be distinguished. (A4–E4) The
central sections through the cryo-EM density maps were displayed in the same sequence as above. Capsids were cut vertically through the 2-, 3- and 5-fold icosahedral
symmetry axes (black lines), with the central 2-fold axis appearing at the 12 o'clock position, and a scale bar equal to 10 nm.
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spectrometry at OD405/490. The neutralization data was plotted at
each antibody concentration and was used to determine the half-
maximum neutralization titer.
Cryo-electron microscopy
To produce HPV16-H16.1A complexes, puriﬁed HPV16 virions and
Fabs were incubated for one hour at room temperature and con-
centrated to 1.2 mg/ml in PBS buffer. An aliquot of 3 ml of complex
was pipetted onto a Quantifoil R2/1 grid (Quantifoil Micro Tools
GmbH, Jena, Germany) and blotted to remove excess sample before
plunging into a liquid ethane-propane mixture using an Mk III
Vitrobot (FEI, Hillsboro, OR) (Tivol et al., 2008). Low-dose conditions
were used to record images on Kodak SO-163 ﬁlm (Kodak, Rochester,
NY) in an FEI TF-20 cryo-electron microscope, which was operated at
200 kV at a nominal magniﬁcation of 50,000 . The microscope
was equipped with a Gatan 626 cryo-holder (Gatan, Inc., Pleasanton,
CA). Cryo-EM images were collected with a defocus range of
1.78–3.96 mm. Films were scanned using a Nikon Super Coolscan
9000 (Nikon, Melville, NY), giving a calibrated pixel size at the
sample of 1.3 Å/pixel. A similar procedure was used to collect data for
the HPV16-H16.14J and -H263.A2 complexes, which were vitriﬁed on
Quantifoil holey carbon support grids (Quantifoil, Jena, Germany)
that were plunged into liquid ethane using a Cryoplunge 3 (Gatan,
Pleasanton, CA). Low dose conditions were used to record digital
images on an Ultrascan 4000 CCD camera (Gatan, Pleasanton, CA) in
a JEOL 2100 LaB6 cryo-EMmicroscope (JEOL, Peabody, MA) operating
at 200 kV and equipped with a Gatan 626 cryo-holder. The recorded
CCD data for HPV16-H16.14J and H263.A2 complexes had calibrated
pixel sizes of 2.33 Å/pixel, and 2.86 Å/pixel; nominal magniﬁcations
of 50,000 , 40,000 ; and defocus ranges of 0.62–4.69 mm, and
1.49–5.52 mm (Table 1), respectively. AUTO3DEM and EMAN2 pro-
gram suites were used for all image processing and 3D reconstruc-
tions (Yan et al., 2007; Tang et al., 2007).
Icosahedral reconstruction
Virus–Fab complexes were selected frommicrographs and used
for calculating 3D reconstructions (Table 1). Semiautomatic parti-
cle selection was performed using EMAN2's e2boxer.py to obtain
the particle coordinates, followed by particle extraction, lineariza-
tion, normalization, and apodization of the images using AUTO3-
DEM (Yan et al., 2007; Tang et al., 2007). Each icosahedrally
averaged reconstruction was initiated using a random model
generated from the raw data (Yan et al., 2007) and the resolution
was estimated where the Fourier Shell Correlation (FSC) dropped
below 0.3 (Fig. 2). To correct for contrast transfer function, defocus
and astigmatism values were assessed over the digitized images
using ctfﬁnd3 and correction was applied in AUTO3DEM (Yan
et al., 2007; Tang et al., 2007).
Fitting the Fab structures into corresponding cryo-EM density
Following a classic ﬁtting protocol (Rossmann et al., 2005, 2001;
Rossmann, 2000), the difference maps were calculated by scaling and
subtracting the virus density from each HPV16-Fab complex map.
Four Fab densities marked as 1 to 4 on the asymmetric unit of HPV16
capsid were used for ﬁtting, excluding the two clashing Fab densities
near the pentavalent capsomer (Fig. 3A). Fab structural models were
predicted according to the amino acid sequence using the Rosetta
Online Server, ROSIE (http://rosie.rosettacommons.org/antibody)
(Lyskov et al., 2013). These ROSIE models were ﬁtted into the related
densities in each of the HPV16-Fab complexes with the crystal stru-
cture of a murine Fab used for ﬁtting the constant domain (PDB ID
3GK8) (Hafenstein et al., 2009). The Fabs were ﬁtted stepwise, with
the constant domain being ﬁtted prior to placing the ROSIE model for
each variable domain. Four of the six Fabs corresponding to one
asymmetric unit were ﬁtted into the difference map. The resulting
ﬁtted structure was then placed into the complex map and reﬁned
simultaneously with the crystal structure of the HPV16 L1 pentamer
(Protein Data Bank PDB ID 3OAE) (Dasgupta et al., 2011) using Situs
(Wriggers, 2010). However, to ﬁt successfully H263.A2, the approach
had to be modiﬁed to include ﬁtting of the variable domain simu-
ltaneously with constant domain of 3GK8 (Wriggers, 2010; Pettersen
et al., 2004). Contacts between the ﬁtted crystal and ROSIE structures
were identiﬁed using Chimera with the criteria of negative cutoff
values of 0.4 Å and an allowance of 0.0 Å to assign van der Waals
overlap distances. All glycines in the interface were excluded from
the epitope due to the limited likelihood of contributing to bonds or
antigenicity.
To identify the correct Fab placement, the Fab was ﬁtted and
reﬁned in two orientations according to its pseudo-two-fold
symmetry axis between the heavy and light chain (Fig. 3B and
C). The ﬁtting quality was evaluated by four structural criteria:
correlation coefﬁcient number, number of clashes (Fig. 3D), elbow
Table 1
CryoEM image reconstruction data. For all maps the resolution was assessed at FSC¼0.3 as reported in Fig. 2 and Methods.
HPV16-V5a HPV16-1A HPV16-14J HPV16-263A2
Number of micrographs 411 80 385 264
Defocus level range (mm) 0.69–3.99 1.78–3.96 0.62–4.69 1.49–5.52
Number of particles selected from micrographs 2306 2071 7074 8908
Number of particles used for reconstruction 2075 1657 5642 6231
Final resolution (Å) 12.0 10.6 12.0 12.1
a Lee et al. (2014).
Fig. 2. Plot showing Fourier shell correlation (FSC) versus spatial frequency of the
icosahedrally averaged reconstructions for each of the virus–Fab complexes. The
resolutions of the reconstructions (10.6 Å for HPV16-1A, 12.0 Å for HPV16-14J, and
12.1 for HPV16-263.A2) were assessed where the FSC curve crossed a correlation
value of 0.3. Due to different pixel sizes in the reconstructions, the FSC curves
ended at different frequency values.
J. Guan et al. / Virology 483 (2015) 253–263256
angle, and surface charge (Pettersen et al., 2004). Stereographic
projections were made using the program RIVEM (Xiao and
Rossmann, 2007). The buried surface area was calculated using
a 1.70 Å probe through the CCP4 program AREAIMOL (Collab-
orative Computational Project, 1994).
Cryo-EM maps for the capsid and capsid–Fab complexes are
deposited in the EM database (http://www.emdatabank.org/) with
accession numbers EMD-5990 (capsid-H16.1A), -6121 (capsid-
H16.14J), and -6184 (capsid-H263.A2). Fitted structures of Fab
(ROSIE) and PDB ID 3OAE are deposited in the PDB: 3J8Z
(H16.1A), 3J8V (H16.14J) and 3J8W (H263.A2) respectively.
Results
The cryo-EM image reconstructions for each of the three fab-labeled
HPV16 complexes showed strong Fab densities
For each complex, HPV16 virus was incubated with excess Fab
and the quality of the HPV16-Fab preparation was conﬁrmed by
negative stain transmission electron microscopy (TEM) before
proceeding to cryo-EM data collection. The icosahedral symmetry
of the HPV16-Fab complexes was readily apparent in low-dose
cryo-EM images (Fig. 1B1–E1). All the Fab-complexed particles
displayed nearly spherical outer proﬁles with a highly uniform
diameter around 71–72 nm, which was signiﬁcantly larger than
the 59 nm diameter of the virus alone (Fig. 1A1) and consistent for
HPV with Fab bound (Lee et al., 2014). Uniformly, the virus–Fab
complex maps clearly showed bulbs of Fab density bound in nearly
saturating amounts.
The three dimensional (3D) reconstructions (Fig. 1A2–E2) were
comparable with resolutions of 11–12 Å, as estimated where the
Fourier shell correlation (FSC) dropped below 0.3 (Fig. 2). Fab
density was located on the distal-most surface of each L1 cap-
somer unit bound at 401 angle relative to the virus capsid. The
heavy and light chain domains were clearly identiﬁed in the Fab
densities which covered the top of the star-shaped capsomers,
leaving only the small central dimple free of Fab (Fig. 1A3–E3).
Central sections through the cryo-EM density maps of capsids and
Fab-labeled capsids illustrated the magnitude of the protein
density (Fig. 1A4 and E4) and the quality of the cryo-EM maps.
The Fab densities with clear constant and variable domains were
identiﬁed near the edge of the capsid shell and it was evident that
the Fab fragments bound to the distal tips of the capsomers.
Most of the Fabs from adjacent capsomers were in close
proximity to one another and radiated outwardly from the intra-
capsomer regions without steric interference. This mode of bind-
ing allowed near saturation of binding sites as attested by the Fab
density being nearly equal in magnitude to that of the capsid. For
every Fab binding to a pentavalent capsomer site there was a clash
with the nearest Fab bound to the neighboring hexavalent cap-
somer (Fig. 3A). Thus due to these steric limitations only one Fab
was bound to either the pentavalent or hexavalent site, which
made the total occupancy decrease from 360 to 300.
Atomic models were generated for Fabs based on sequence
The sequence of the variable regions of H16.1A, H16.14J, and
H263.A2 were aligned and annotated so that the complementarity
determining regions (CDRs) of both the antibody heavy and light
chains could be assigned using the Rosetta online server (ROSIE)
(Methods). Because the atomic structures of the Fabs were unknown,
a ROSIE model was predicted for each based on the high structu-
ral conservation of the constant domains and the sequence of
Fig. 3. Fitting of four Fabs on one asymmetric unit of capsid. (A) Four Fab densities marked as 1 to 4 on an asymmetric unit of the HPV16 capsid were used for ﬁtting. The
icosahedral 2-fold, 3-fold and 5-fold symmetry axes are indicated and the hexavalent capsomer is marked on the virus–Fab complex density map (gray mesh). Due to the
pseudo-two-fold symmetry axis between Fab heavy (Blue) and light chains (Orange), two ﬁtting modes were used for reﬁnement of ﬁt: the Fab heavy chain facing outwards
from the center of the capsomer (B) and Fab light chain facing outwards (C). Statistics for the ﬁtted Fab structures into corresponding cryo-EM density are reported for both
ﬁtting modes (D) according to the correlation coefﬁcient and the number of atomic clashes with the ﬁtted virus structure (crystal structure of the HPV16 L1 pentamer,
Protein Data Bank, PDB ID 3OAE) (47)).
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the variable domains (Lyskov et al., 2013). Although the virus-H16.V5
cryo-EM structure was described elsewhere (Lee et al., 2014), the
sequence of H16.V5 is reported for the ﬁrst time here. Most of the
differences between Fabs were found in the CDRs (Fig. 4). Among
the heavy chain sequences, H16.14J had the most variability
within the framework region. However, compared to the light chain
sequences, the heavy chains are largely conserved. Among the
differences between the light chains, H263.A2 and H16.14J appear
to be the most divergent from H16.1A and H16.V5. Additionally,
H263.A2 and H16.14J have the most differences within the frame-
work region compared to the H16.V5 and H16.1A sequences.
Fitting of Fab models and capsid atomic structures into the cryo-EM
density maps
For ﬁtting experiments, each of the three complex maps was
used to calculate a difference map by subtracting a scaled virus map
of similar quality. Into each difference map, the correct ROSIE Fab
model was ﬁtted and reﬁned within each of the three complete Fab
difference densities in the asymmetric unit of the capsid (Fab1-4)
(Fig. 3A). The ﬁtted Fabs were then placed into the corresponding
complex map where they were simultaneously reﬁned with the
virus pentamer structure (PDB ID: 3OAE) (Dasgupta et al., 2011)
using the program Situs (Wriggers, 2010). Because of the Fab
pseudo-2-fold symmetry axis, the heavy and light chains could be
ﬁtted into the same density in two orientations related by a 1801
rotation (Fig. 3B and C). Each Fab was ﬁtted and reﬁned in both
possible orientations, and the quality of the different docking modes
was quantiﬁed by different ﬁtting criteria (Fig. 3D). The correlation
coefﬁcient (cc) numbers for all ﬁttings were high (40.9); the
differences (1%) between the two orientations were too slight to
use the cc alone to assign correct placement of the Fab. For each, the
angle between the two pseudo-dyad rotation axes of the variable
heavy and light chain and constant heavy and light chain (elbow
angle) of the Fab was in the range of 140–1801 which was within the
observed range for a Fab elbow angle of 127–2251 (Wilson and
Stanﬁeld, 1994). Thus the correct orientations of the Fabs could also
not be identiﬁed by elbow angle alone.
The number of atoms between the ﬁtted Fab and pentamer
structure that were identiﬁed to be in positions of steric
collision was then used to evaluate the correct binding mode.
An orientation with the heavy chain facing away from the center
of the capsomer (outward) resulted in fewer clashing atoms
compared to the light chain facing outward mode for two of the
Fig. 4. Sequence alignment of the heavy chain (A) and light chain (B) variable regions of H16.1A, H16.14J, H16.V5, and H263.A2. Complementarity determining regions (CDR
1-3) were annotated at the top of the alignment with each framework region (FR 1-4) annotated in the same manner. The consensus sequence was displayed as the last
sequence and red residues indicate differences among the sequences.
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three Fabs: H16.1A, and H263.A2. However, this approach was
inconclusive for H16.14J because a similar number of clashes were
deﬁned in both orientations. To assess further the binding orientation
for H16.14J, a Coulombic Surface Color model was generated for the
ﬁtted Fab and capsomer (data not shown). Based on the predicted
charge interactions, the heavy chain facing-out model was proposed
for H16.14J binding. The ﬁtting of each Fab was reﬁned using the
heavy chain outwards orientation and the buried surface area was
calculated. H16.V5 had a buried surface of 1467.7 Å2 calculated on the
previously published binding mode (Lee et al., 2014). H263.A2 had a
similar area of 1402.5 Å2; however both H16.1A (1159.8 Å2) and
H16.14J (927.7 Å2) had signiﬁcantly smaller buried surface.
Epitope analysis showed multiple L1-loop participation
The reﬁned ﬁtting of the Fab and capsomer structures produced
a pseudo-atomic model that was used for epitope analysis. Based on
distance and geometry, all potential interactions between Fab and
virus were identiﬁed (Table 2). Each Fab, including H16.V5, mapped
to the surface of the virus with a distinct and different footprint;
however, each of the four footprints involved multiple loops from
more than one L1 protein. The epitope for H263.A2 included loops
from three of the L1 proteins comprising the capsomer whereas
H16.V5 (Lee et al., 2014), H16.1A, and H16.14J involved two neig-
hboring copies of L1. Other speciﬁc differences included that H16.V5
and H16.1A did not have any BC loop interactions and H16.14J had
the fewest DE and FG loop interactions.
Distances between ﬁtted Fabs indicate monovalent or bivalent
binding modes
For an antibody to be able to bind bivalently, the distance between
the C-terminal Cα atoms of adjacent heavy chains is typically in the
range of 25–29 Å (Wilson and Stanﬁeld, 1994; Smith et al., 1993;
Hewat and Blaas, 1996). For the ﬁtted Fabs, the distance was mea-
sured across the two-, three- and ﬁve-fold symmetry axes (Table 3)
between the closest adjacently bound Fabs. H16.V5, H16.14J, and
H263.A2 bound to the capsid at distances ranging from 35 to 154 Å,
depending on the orientation, suggesting they are incapable of biv-
alent binding. However, at the three-fold symmetry axis, H16.1A Fab
molecules were 27.5 Å apart, indicating that bivalent binding might
be possible.
All four mAbs, H16.V5, H16.1A, H16.14J, and H263.A2 neutralize better
than their Fabs
Intact mAb or Fab was pre-incubated with virus and applied to
host cells in pre-attachment neutralization assays. In separate
complementary experiments virus was allowed to attach to the
cell surface ﬁrst, followed by the addition of mAb or Fab in post-
attachment neutralization assays. The mAb neutralization ability
was similarly efﬁcient between pre- and post- attachment assays
for all of the four antibodies (Fig. 5A and C). Fab from each of the
mAbs tested was capable of neutralization; however, at a much
reduced efﬁciency (Fig. 5B and D). H16.1A Fab neutralized better in
post-attachment than pre-attachment assays, whereas the reverse
was true of H16.14J that neutralized better in pre-attachment
assays. In each case, the intact antibody was more efﬁcient at
neutralization than the respective Fab, suggesting the bivalency of
the mAbs may provide an enhancement in neutralization.
Discussion
By ﬁtting the atomic structures of Fab and virus into the 12 Å
cryo-EM complex density maps, the structures could be analyzed at
near-atomic resolution (Rossmann et al., 2005, 2001; Rossmann,
2000). Because a Fab structure has a pseudo-dyad axis, two orie-
ntations related by a 1801 rotation can be generated when ﬁtting a
Fab structure into density. The correct orientation for the ﬁtted Fabs
was identiﬁed according to multiple criteria, including correlation
Table 2
The pseudo-atomic models identiﬁed residues of HPV16 predicted to interact with
Fab and deﬁne the antigenic epitopes. In the contact region, two or three L1
proteins of the capsomer interacted with each Fab. For each footprint the copy of
the L1 protein that made the major contributions is designated with a blue X, and
additional minor interactions were made by a second neighboring L1 (indicated by
red X0). In only one case, mAb HPV.263.A2, there was a third copy of L1 involved in
the conformational epitope (green X″). nThe H16.V5 result included here was from
our previously published paper (Lee et al., 2014). The alternative mode of binding
for the light chain facing out has been included as supplemental material.
L1 Protein Surface Loop Fab
V5* 1A 14J 263A2
BC 54 LYS X0
55 PRO X0 X0
DE 135 TYR X X
136 ALA X X
137 ALA X X
138 ASN X X X X
139 ALA X X X X
141 VAL X X0
142 ASP X X0
143 ASN X
EF 181 GLN X X X X
182 PRO X X
184 ASP X
FG 267 VAL X
269 GLN X
270 ASN X X
273 ASP X
278 LYS X X
280 SER X X X
282 SER X X X X
283 THR X X
284 ALA X X
285 ASN X X X X
286 LEU X X
287 ALA X
HI 348 ILE X0 X0 X0
354 THR X0 X″
358 THR X0 X0 X0 X0
361 LYS X0 X0 X0 X0
Table 3
The distance between C-terminal heavy chain Cα atoms between the nearest
icosahedrally related adjacently bound Fabs. Since there were three pairs of Fabs
related by icosahedral two-fold symmetry, three distances were measured sepa-
rately and listed in the table. Calculation of H16.V5 was included for comparison





Distance (Å) to nearest symmetry-related Fab heavy chain
outwards
Two-fold Three-fold Five-fold
V5 93.8/97.2/154.8 36.6 81.2
1A 67.9/108.3/139.5 27.5 76.4
14J 94.8/95.5/152.3 35.5 79.9
263A2 92.9/95.8/154.8 35.3 78.9
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coefﬁcient, steric interference between ﬁtted molecules, Fab elbow
angle, and surface charge compatibility (Fig. 3D). The best binding
mode was determined to be with the heavy chain facing out, away
from the center of the capsomer. Results from previous immuno-
logical studies (Christensen et al., 2001; Rizk et al., 2008) corrobo-
rate this mode of binding. For example, BC loop interactions have
been shown for H16.14J using hybrid loop exchange experiments
(Christensen et al., 2001). For the ﬁtted H16.14J Fab, interactions
with the BC loop were only detected when the Fab was placed into
the density with the heavy chain facing outward. For H16.1A and
H263.A2, EF loop participation was demonstrated previously
(Christensen et al., 2001) and EF interactions were only identiﬁed
in the Fab ﬁtting with the heavy chain facing outward. Nevertheless,
the interactions predicted for ﬁtted Fabs with the light chain facing
outward have been included as Supplementary material.
All four antibody footprints involved multiple loops from two
or three L1 capsid proteins (Table 2, Figs. 6 and 7). Collectively the
Fab footprints on the surface of the virus mapped to a topogra-
phical “groove” in the capsomer (Fig. 6). Most of the FG, HI, and DE
loops contributed to this groove whereas only smaller portions of
the EF and BC loops were included. The Fab molecules ﬁlled the
grooves on the capsomer crown, perhaps serving as a physical
obstacle to block the loop movements necessary during virus
conformational changes. Due to this mode of Fab binding and the
interaction with multiple loops from more than one L1 molecule,
the Fabs likely neutralize by stabilizing the capsomer and locking
it into one conformation. As was shown previously with H16.V5,
loop stabilization at the binding site was propagated throughout
the capsid leading to hyperstabilization (Lee et al., 2014).
Since the internalization of bound virions is a slow process
with a half-life of hours (Day and Schelhaas, 2014; Raff et al.,
2013), the virions remain accessible on the cell surface. However,
virus binding to cell receptors triggers conformational changes to
the capsid (Zhao et al., 2014). Thus, during the post-attachment
assays, conformational changes of the capsid triggered by attach-
ing to the cell may have affected binding and neutralization. H16.
V5 and H236.A2 Fabs showed only slight differences of neutraliza-
tion ability between pre- and post-attachment (Fig. 5), which
suggests the capsid conformational changes had little or no effect
on the antibody footprints for these Fabs. There are signiﬁcant
differences in pre- and post-attachment neutralization by H16.1A
and H16.14J Fabs (Fig. 5) suggesting that capsid conformational
changes overlap with the epitopes of these two Fabs.
Footprints for H16.1A and H16.14J involved fewer residues on
the virus surface as was seen by the signiﬁcantly smaller buried
surface compared to H16.V5 and H263.A2 (around 20% to 35%
smaller areas). Speciﬁcally, our results predict H16.14J will make
fewer interactions with DE and FG loops whereas the epitope of
Fig. 5. Neutralization was assessed pre- and post-attachment to host cells. PsVs were pre-incubated with mAb (A) or Fab (B) at the indicated dilutions at physiological
temperature prior to adding to cells. Alternatively, PsVs were incubated with cells for 1 h for attachment before applying mAb (C) or Fab (D). The neutralization titers were
graphed as % neutralization (Methods).
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H16.V5, H16.1A and H263.A2 showed larger “core areas” formed
by FG and DE loops with less participation of BC, EF, and HI loops
(Table 2). Thus H16.14J, with fewer key interactions and less buried
surface, must rely on the coordination of all ﬁve loops for an
interaction and may have been more affected by the virus chan-
ging conformation during capsid attachment. For H16.1A, an
enlarged or improved epitope may have been formed during L1
conformational changes during cell attachment, which enhanced
the neutralizing ability of H16.1A. H16.V5, and H263.A2 were not
affected by virus attachment, probably because these two anti-
bodies have more DE and FG loop interactions and larger buried
surface.
Mapping each epitope onto the roadmap of a single capsomer
showed the similarities and differences (Fig. 7). The virus residues
that interact with all four mAbs were mapped as a common epitope
that consisted of ASN138.DE, ALA139.DE, GLN181.EF, SER282.FG,
ASN285.FG, ILE348.HI, and LYS361.HI (Fig. 6). Among these seven
residues may be the essential interactions for effective neutralization.
Participation of multiple loops from different L1 proteins for
the antibodies agrees with previous studies suggesting a stabiliza-
tion mechanism of neutralization (Lee et al., 2014; Day et al., 2007,
2008; Deschuyteneer et al., 2010). However, mAbs showed sig-
niﬁcantly higher neutralization efﬁciency than Fabs, suggesting
that the bivalency of the antibody may have a role to play in
addition to the hyper-stabilization mechanism induced by the Fab-
capsid interaction. Previous studies have shown that an intact
antibody can bind bivalently to one capsid surface to stabilize or
bind monovalently with two capsids (Hewat and Blaas, 1996) to
Fig. 6. The location of the antibody binding groove on the surface of capsomer was
made up of FG and DE loops with lesser contributions by the BC, EF, and HI loops.
All four epitopes map to a “groove” feature on the surface of the capsomer (upper
right, dashed outline). The combined four footprints are color coded according to
loop identity (lower right, dashed box). The left column shows the zoomed view of
the individual epitopes of H16.V5, H16.1A, H16.14J, and H263.A2 with speciﬁc loop
contributions indicated by color (Top: color code bar for DE, EF, HI, BC, and FG).
Fig. 7. The roadmap shows the footprint of each antibody mapped to the stereographic projection of a capsomer. The virus surface was represented as a quilt of amino acids,
shown as a projection, for the icosahedral asymmetric unit, with the polar angles φ and θ representing the latitude and longitude (58). As in Fig. 6, the color bar identiﬁes the
contribution of the different antigenic L1 loops to each mAb epitope (dashed circle). The common epitope (arrow) includes all residues identiﬁed in each mAb footprint.
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induce aggregation through cross-linking of viruses. Three of the
four antibodies, H16.V5, H16.14J, and 263.A2, were clearly capable
of monovalent binding (crosslinking) and incapable of bivalent
binding (Table 3) as neighboring Fabs were too far apart. H16.1A is
capable of bivalent binding at the three-fold, and monovalent
binding at other sites. This complexity of binding suggests the
process of mAb neutralization was more complicated than that for
the corresponding Fab.
Here, we propose a model of neutralization by four HPV16 spe-
ciﬁc mAbs, H16.V5, H16.1A, H16.14J and H263.A2. These antibodies
and their Fabs are likely capable of neutralizing by hyperstabilizing
the capsid through interactions involving multiple loops from diff-
erent L1 proteins. However, the structural analysis and functional
assays indicate that bivalency of the intact antibody enhances or
complements this type of neutralization. Likely mAbs neutralize by
multiple mechanisms, including stabilization, crosslinking, and biv-
alent binding.
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